Phosphodiesterases as therapeutic targets.
Lin
Ching-Shwun
CS
Knuppe Molecular Urology Laboratory, Department of Urology, University of California, San Francisco, School of Medicine, 94115, USA.
Xin
Zhong-Cheng
ZC
Lin
Guiting
G
Lue
Tom F
TF
D007172:Erectile Dysfunction / Q000188:drug therapy; D005544:Forecasting; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D010413:Penis / Q000201:enzymology / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010727:Phosphoric Diester Hydrolases / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy; D013379:Substrate Specificity; D014018:Tissue Distribution; D014549:Urinary Incontinence / Q000188:drug therapy; D016055:Urinary Retention / Q000188:drug therapy / Q000209:etiology; D014570:Urologic Diseases / Q000188:drug therapy
D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases